ID: ALA3906269

Max Phase: Preclinical

Molecular Formula: C15H8Br2N2O2

Molecular Weight: 408.05

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1ccc2c3n(c(=O)c(=O)cc1-3)c1c(Br)cc(Br)cc21

Standard InChI:  InChI=1S/C15H8Br2N2O2/c1-18-3-2-8-9-4-7(16)5-10(17)13(9)19-14(8)11(18)6-12(20)15(19)21/h2-6H,1H3

Standard InChI Key:  LUKSFALCZJHUPP-UHFFFAOYSA-N

Associated Targets(non-human)

Meriones unguiculatus 417 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 408.05Molecular Weight (Monoisotopic): 405.8953AlogP: 3.22#Rotatable Bonds: 0
Polar Surface Area: 43.48Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.42Np Likeness Score: -0.02

References

1. Sasaki T, Li W, Ohmoto T, Koike K..  (2016)  Evaluation of canthinone alkaloids as cerebral protective agents.,  26  (20): [PMID:27623547] [10.1016/j.bmcl.2016.09.006]

Source